⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
La Fundación Global para una Vida Saludable Amplía El Acceso A Educación e Información Sobre Ensayos Clínicos Para Comunidades Hispanohablantes Con Lupus
businesswire.com
BMY
Incyte Japan gibt die Zulassung von Minjuvi ® (Tafasitamab) in Kombination mit Rituximab und Lenalidomid zur Behandlung von rezidiviertem oder refraktärem follikulärem Lymphom bekannt
businesswire.com
INCY
BMY
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
businesswire.com
BMY
Mike Tyson on Discipline, Power and the Cost of Greatness; World Heavyweight Champion Sits Down With Visionary Entrepreneur Sean Callagy for Unforgettable Episode of "Unblinded" Podcast
accessnewswire.com
BMY
DIS
CRM
TMUS
MA
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
businesswire.com
BMY
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
globenewswire.com
BNTX
CVAC
BMY
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
PFE
SNY
TSEM
JNJ
LLY
MRK
BMY
ABBV
GILD
CRSP
NKTR
INCY
Building a Healthier Future Together: Strengthening Cancer Care Across Africa Through Partnership
accessnewswire.com
BMY
United States Multiple Myeloma Market Report: Growth Drivers and Challenges 2025-2033
globenewswire.com
ABBV
JNJ
PFE
BMY
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
globenewswire.com
ABBV
BMY
GILD
AMGN
AZN
LLY
BIIB
REGN
VRTX
XBI
IBB
CRSP
EDIT
NTLA
ABCL
NVS
MRK
PFE
JNJ
GSK
SNY
BTAI
INSM